Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Recurrent Glioblasta Multiforme
Trial Name: A Randomized Phase I/II Study of ABT-888 In Combination With Temozolomide In Recurrent (Temozolomide Resistant) Glioblastoma
Protocol ID: RTOG 0929
Anticipation of need for major surgical procedures during the course of the study
Enrollment: 240 patients
Taking part in this study may or may not make your health better. While researchers hope that the combination of temozolomide and ABT-888 will be more useful against cancer compared to the usual treatment, there is no proof of this yet. We do know that the information from this study will help researchers learn more about this drug combination as a treatment for cancer. This information could help future cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.
Created: Jan 18, 2013
Updated: Jan 18, 2013